Nektar Therapeutics (NKTR)
Market Open
26 Oct, 06:12 PM
$
37. 38
+0.16
+0.4433%
$
1.07B Market Cap
- P/E Ratio
- Div Yield
11,130 Volume
-0.72 Eps
$ 37.22
Previous Close 
Want to track NKTR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.25 |
| | | - | - |
| | | 0.39 | 0.53 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
NKTR Earnings Reports FAQ
What is the earnings per share (EPS) for NKTR?
The current EPS is -0.72.
What is the company's earnings growth rate?
Nektar Therapeutics has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Nektar Therapeutics has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Nektar Therapeutics are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for NKTR at this time, as Nektar Therapeutics has no recent EPS data to calculate it.
2026 © Marketlog. All Rights Reserved.
